Secukinumab does not impair the immunogenic response to the influenza vaccine in patients

OBJECTIVE: To evaluate whether immunological response to influenza vaccination is impaired in patients who are receiving secukinumab. PATIENTS AND METHODS: Subjects suffering from psoriatic arthritis or ankylosing spondylitis who were receiving treatment with secukinumab and healthy volunteers were...

Descripción completa

Detalles Bibliográficos
Autores principales: Richi, Patricia, Martín, María Dolores, de Ory, Fernando, Gutiérrez-Larraya, Rosa, Casas, Inmaculada, Jiménez-Díaz, Ana María, Cava, Fernando, Muñoz-Fernandez, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744077/
https://www.ncbi.nlm.nih.gov/pubmed/31565246
http://dx.doi.org/10.1136/rmdopen-2019-001018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744077/
https://www.ncbi.nlm.nih.gov/pubmed/31565246
http://dx.doi.org/10.1136/rmdopen-2019-001018

Ejemplares similares